We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $500B Turnover 17.06%
1-Year Est. Return 36.84%
 

Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.

This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+36.84%
3 Year Est. Return
+152.89%
5 Year Est. Return
+181.78%
10 Year Est. Return
+662.03%
AUM
$500B
AUM Growth
-$20.6B
Cap. Flow
-$19B
Cap. Flow %
-3.79%
Top 10 Hldgs %
39.98%
Holding
5,855
New
525
Increased
2,900
Reduced
1,494
Closed
474
Avg Time Held Equity + Options
5.6 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.9 years
Avg Time Held Equity only
6.5 years
Top 10 Avg Time Held Equity only
4.6 years
Top 20 Avg Time Held Equity only
5 years

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$17.5B
2
NVDA icon
NVIDIA
NVDA
+$2.7B
3
INTC icon
Intel
INTC
+$1.98B
4
AVGO icon
Broadcom
AVGO
+$1.46B
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.11B

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.47%
2 Technology 19.84%
3 Consumer Discretionary 7.61%
4 Financials 5.61%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VOR icon
3651
Vor Biopharma
VOR
$1.23B
$335K ﹤0.01%
17,541
+2,976
+20% +$63.5K
2025 Q4
3 quarters
RM icon
3652
Regional Management Corp
RM
$315M
$333K ﹤0.01%
11,012
+2,275
+26% +$80.8K
2013 Q2
53 quarters
TMCI icon
3653
Treace Medical Concepts
TMCI
$330M
$332K ﹤0.01%
71,948
+20,318
+39% +$91.1K
2022 Q1
18 quarters
SOLS icon
3654
CALL
Solstice Advanced Materials
SOLS
$10.6B
$332K ﹤0.01%
5,900
– –
2025 Q4
3 quarters
GSM icon
3655
FerroAtlántica
GSM
$534M
$331K ﹤0.01%
83,188
+29,455
+55% +$115K
2025 Q1
6 quarters
WEST icon
3656
Westrock Coffee
WEST
$839M
$331K ﹤0.01%
41,123
+5,669
+16% +$44.7K
2023 Q2
13 quarters
RCEL icon
3657
Avita Medical
RCEL
$545M
$330K ﹤0.01%
28,158
+27,403
+3,630% +$217K
2023 Q2
13 quarters
WRN icon
3658
Western Copper and Gold
WRN
$344M
$330K ﹤0.01%
149,416
+4,200
+3% +$9.7K
2026 Q1
2 quarters
KEP icon
3659
Korea Electric Power
KEP
$14.6B
$330K ﹤0.01%
30,120
+29,027
+2,656% +$341K
2025 Q4
3 quarters
ENPH icon
3660
PUT
Enphase Energy
ENPH
$3.72B
$330K ﹤0.01%
10,000
-45,000
-82% -$1.73M
2024 Q3
8 quarters
AVBH icon
3661
Avidbank Holdings
AVBH
$382M
$328K ﹤0.01%
10,601
+1,296
+14% +$41.6K
2025 Q4
3 quarters
FPH icon
3662
Five Point Holdings
FPH
$318M
$328K ﹤0.01%
70,087
– –
2017 Q2
37 quarters
CNDT icon
3663
Conduent
CNDT
$212M
$328K ﹤0.01%
210,075
+37,213
+22% +$59.9K
2017 Q1
38 quarters
SOC icon
3664
CALL
Sable Offshore Corp
SOC
$170M
$327K ﹤0.01%
94,600
-139,600
-60% -$622K
2026 Q2
1 quarter
AVO icon
3665
Mission Produce
AVO
$1.03B
$325K ﹤0.01%
24,820
+17,029
+219% +$220K
2022 Q1
18 quarters
NB icon
3666
NioCorp Developments
NB
$431M
$325K ﹤0.01%
90,333
+28,950
+47% +$125K
2023 Q2
13 quarters
PFIS icon
3667
Peoples Financial Services
PFIS
$728M
$325K ﹤0.01%
4,818
+3,446
+251% +$240K
2017 Q1
38 quarters
TTI icon
3668
TETRA Technologies
TTI
$935M
$323K ﹤0.01%
55,072
+33,784
+159% +$260K
2021 Q1
22 quarters
FDUS icon
3669
Fidus Investment
FDUS
$778M
$323K ﹤0.01%
+16,770
New +$331K
2026 Q3
0 quarters
NECB icon
3670
Northeast Community Bancorp
NECB
$400M
$323K ﹤0.01%
12,414
+1,568
+14% +$41.9K
2022 Q3
16 quarters
DIN icon
3671
Dine Brands
DIN
$455M
$323K ﹤0.01%
11,589
+8,245
+247% +$274K
2013 Q2
53 quarters
MLAB icon
3672
Mesa Laboratories
MLAB
$797M
$322K ﹤0.01%
2,479
+1,650
+199% +$187K
2016 Q3
40 quarters
AIRJ icon
3673
Montana Technologies Corp
AIRJ
$178M
$322K ﹤0.01%
82,560
+77,348
+1,484% +$360K
2025 Q2
5 quarters
TREE icon
3674
LendingTree
TREE
$519M
$321K ﹤0.01%
13,130
+3,354
+34% +$112K
2020 Q4
23 quarters
SIBN icon
3675
SI-BONE Inc
SIBN
$1.12B
$320K ﹤0.01%
17,001
-3,133
-16% -$57.3K
2018 Q4
31 quarters

Similar funds

Barclays's Q3 2026 Portfolio in Review

As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.

  • Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
  • Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
  • Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
  • Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
  • Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
  • Barclays opened 525 new positions and closed 474 in Q3 2026.
  • Barclays's portfolio value fell 4% quarter-over-quarter to $500B.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.